Search

everythinglearnresearchcommunity

for

Search:↓

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

FOXN1 gene variants cause low T cells and immune issues from birth.

Researchers used CRISPR/Cas9 to create a goat with a gene that increased cashmere production by 74.5% without affecting quality.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Regulatory T cells enhance bone formation by influencing cell mechanics.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.